Creation of a synthetic indicator of quality of care as a clinical management standard in primary care

Coma, Ermengol; Ferran, Manel; Méndez, Leonardo; Iglesias, Begoña; Fina, Francesc; Medina, Manuel

doi:10.1186/2193-1801-2-51

SpringerPlus

Table 1 Structure and weighted scoring of the synthetic indicator “Healthcare Quality Standard 2007

From: Creation of a synthetic indicator of quality of care as a clinical management standard in primary care

Clinical condition in adults		Relative weight
	Indicator
*Ferropenic anaemia*
1	Diagnosis of new cases	14
2	Follow-up	12
*Social assessment*
3	Of individuals who are dependent on family members	13
4	Of frail elderly individuals	16
*Cerebrovascular disease (CVD) and/or transient ischemic attack (TIA)*
5	Antiplatelet/anticoagulant treatment	30
6	Lipid control	26
*Ischemic heart disease (IHD)*
7	Beta-blockers treatment	26
8	Antiplatelet/anticoagulant treatment	26
9	Lipid control	23
*Hypercholesterolemia*
10	Cardiovascular Risk (CVR) record of hypercholesterolemia	30
*Atrial fibrillation (AF)*
11	Antiplatelet/anticoagulant treatment	38
*Arterial hypertension (AHT)*
12	Blood pressure (BP) control	44
13	Blood pressure (BP) control in at-risk population (IHD, DM, CVD/TIA, Chronic Kidney Failure)	25
*Heart failure (HF)*
14	ACEI/ARB treatment	26
15	Beta-blockers treatment	23
*Chronic hepatitis C*
16	Vaccination for hepatitis B virus	23
*Alcohol use*
17	Screening for alcohol use	26
*Tobacco use*
18	Screening for tobacco use in at-risk population	26
19	Smoking cessation	29
*Diabetes mellitus 2 (DM2)*
20	Screening and onset prevention	20
21	HbA1c control	30
22	Screening and prevention of diabetic retinopathy	23
23	ACEI/ARB treatment in DM2 with chronic nephropathy	24
*Cognitive deterioration*
24	Syndrome diagnosis, new cases of cognitive deterioration	17
25	Home health care interventions for a safe living environment for patients with dementia	13
26	Assessment of caregiver burnout	16
*Impacted earwax*
27	Removal of earwax plugs in primary care	10
*Asthma*
28	Diagnosis of new cases of asthma	22
*Vaccinations*
29	Flu shots in patients aged ≥60 years	29
30	Flu shots in at-risk patients	20
31	Pneumonia shots in patients aged ≥60 years	5
32	Tetanus shots	35
*Chronic obstructive pulmonary disease (COPD)*
33	Diagnosis of new cases	23
34	Training in use of COPD inhalers	12
*Home health care (ATDOM)*
35	Case complexity assessment of patients with ATDOM	16
36	Assessment of pressure ulcers risk	26
*PREALT*
37	Contact within 48 hours with PREALT patients	12
*Nephritic colic*
38	Proper treatment of nephritic colic	10
*Prostate cancer*
39	Avoid improper use of PSA	11
Clinical condition in children		Relative weight
	Indicator
*Preventive care*
40	Screening for congenital metabolic diseases	7
41	Introduction of foods at recommended stages	7
42	Systematic infant vaccinations (0–14 years)	10
43	Control of growth and development (0–2 years)	8
44	Screening for passive smoking ≤2-year-olds	7
45	Maintenance of maternal lactation	6
46	Measles vaccination at 13 years	6
47	Dental cavity preventive treatment (6–12 years)	7
48	Screening for ocular diseases (0–6 years)	8
49	Flu shots in at-risk children <15 years	7
50	Screening for toxic habits (11–14 years)	7
*Increasing capacity to resolve cases at primary care level*
51	Umbilical hernia in children ≤3 years	5
52	Contagious mollusk and viral warts (0–14 years )	6
53	Neonatal dacryocystitis <9 months	6
*Acute disease*
54	Treatment of acute gastroenteritis (3 months to 14 years )	7
55	Treatment of tonsillitis, pharyngitis or pharyngotonsillitis <3 years	7
56	Treatment of acute bronchiolitis <2 years	6
57	Treatment of catarrh in upper respiratory infection or flu <15 years	7
58	Treatment of acute nonsuppurative otitis media (2–14 years )	7
*Chronic disease*
59	Diagnosis of childhood asthma (7 a 14 years )	8
60	Calculation of body mass index in obesity or weight gain (6–14 years )	7
*Social assessment*
61	Social assessment of children with a disability (<15 years)	4
Total		1000

Back to article page